Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Nerac Announces the August Issue of the Nerac Strategist

Nerac Announces the August Issue of the Nerac Strategist

Facebook0
Google+0
LinkedIn0
Twitter0

New issue explores regulatory compliance strategies for the Chinese FDA, strategies for innovation and opportunities and challenges in desalination technologies.

Read the full release here.

Related Posts

  • Nerac Announces New Issue of The Nerac Strategist
    62
    November issue offers in-depth business perspectives on industry issues, compliance challenges and commercial opportunities authored by Nerac analysts Read the full release here.
    Tags: nerac, read, issue, challenges, opportunities, compliance, release, full, originally, strategist
  • Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A Nerac Perspective Part III: The Final Clinical Literature Evaluation Report
    56
    By Richard Conforti, M.S., Nerac Analyst, Originally Published: August 15, 2016 In 2014 the Chinese Food and Drug Administration, CFDA, updated their regulations on medical devices. These updates substantially changed the way in which a medical device company, particularly international companies not based or founded in China, registers their devices in China. In the final…
    Tags: cfda, nerac, chinese, read, august, published, originally, compliance, regulatory
  • Webinar: Order 650 – China’s New CLE Requirements for Medical Devices
    56
    Gain a working knowledge of the clinical literature evaluation process for China in the Nerac webinar hosted by FX Conferences: Order 650 – China’s New CLE Requirements for Medical Devices Click here to register. In 2014 the Chinese FDA updated its regulations for medical devices, Order 650, under which manufacturers are now required to perform…
    Tags: regulatory, compliance, cfda
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence Disruptive Technologies emerging markets energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2022 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.